While data has been mainly retrospective, it has ranged from specific patient groups, such as those with hormone receptorpositive disease receiving endocrine therapy 1 or those only receiving semaglutide and tirzepatide with stage I to III breast cancer, 2 to patients from the broader breast cancer population receiving a range of GLP-1 agonists
Genetic Predisposition and Personalized Glutathione Response Individual glutathione synthesis and metabolism are influenced by genetic polymorphisms in genes encoding glutathione-S-transferase (GST), glutathione peroxidase (GPx), and cysteine metabolism enzymes
Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved specifically for chronic weight management in adults with obesity, or overweight with at least one weight-related health condition
Look for reduced glutathione in a true liposomal delivery system, third-party tested for purity and potency
Weight loss via GLP-1 agonists is not just fat loss, so overall body composition must be monitored
Of course, with a smaller overdose, the curves would be higher and with a larger overdose the curves will be lower
